The purpose of this Health Alert Network (HAN) Health Update is to inform clinicians and public health agencies about the potential for new clusters or outbreaks of mpox cases and to provide resources on clinical evaluation, treatment, vaccination, and testing.Ī global outbreak of mpox began in May 2022. Spring and summer season in 2023 could lead to a resurgence of mpox as people gather for festivals and other events.
CDC expects new cases among previously vaccinated people to occur, but people who have completed their two-dose JYNNEOS vaccine series may experience less severe symptoms than those who have not. Travel history was available for 9 cases 4 recently traveled (New York City, New Orleans, and Mexico).Īlthough vaccine-induced immunity is not complete, vaccination continues to be one of the most important prevention measures. The median age was 34 years (range 24–46 years). Confirmed cases were in 9 (69%) non-Hispanic White men, 2 (15%) non-Hispanic Black men, and 2 (15%) Asian men. Nine (69%) of 13 cases were among men who had received 2 JYNNEOS vaccine doses. None of the patients have been hospitalized. From April 17 to May 5, 2023, a total of 12 confirmed and one probable case of mpox were reported to the Chicago Department of Public Health. This week, CDC and local partners are investigating a cluster of mpox cases in the Chicago area. The Centers for Disease Control and Prevention (CDC) continues to receive reports of cases that reflect ongoing community transmission in the United States and internationally. In the United States, cases of mpox (formerly monkeypox) have declined since peaking in August 2022, but the outbreak is not over.
0 kommentar(er)
